Hypoxic states are associated with abnormal proliferation and constriction of the smooth muscle cells surrounding the distal vessels of the lung. In hypoxic as well as in normal states, the endothelial cell layer may play a key role in controlling smooth muscle tone by secreting a number of vasoactive agents. Platelet-derived growth factor (PDGF), produced by endothelial cells, is a major growth factor for vascular smooth muscle cells and a powerful vasoconstrictor. It consists of a disulfide-linked dimer of two related peptides, A and B, that are products of two different genes. We found that hypoxic conditions (0-3% oxygen environments) significantly increased PDGF-B mRNA in cultured human umbilical vein endothelial cells by enhancing the transcriptional rate of this gene. This increase was inversely proportional to oxygen tension and was reversible upon reexposure of cells to a 21% oxygen atmosphere. mRNA levels of PDGF-A were not affected nor was the overall rate of cellular gene transcription increased in response to hypoxia. These studies indicate that endothelial cells are not only capable of sensing oxygen tension, but are also able to discriminate and respond to even small differences in oxygen tension resulting in dramatic upregulation of the PDGF-B chain gene. (J. Clin.
Introduction
Many recent studies have indicated that vascular endothelium regulates smooth muscle vasoactivity. Furchgott and Zawadzki (1) first reported that an intact endothelial cell layer is necessary for the relaxation caused by acetylcholine in isolated rabbit arteries. Since then, endothelial cells have been found to release not only relaxing factors such as prostacyclins and nitric oxide (previously called endothelial-derived relaxing factor) (2) , but also a variety of vasoconstrictive agents. Yanagisawa et al. (3) have identified a potent endothelial-derived vasoconstrictor, endothelin, and others have described a protease-sensitive vasoconstrictor activity in supernatants of aortic endothelial cells (4) . In addition, the endothelium appears to be required for the constrictive effect of hypoxia on isolated canine coronary arteries (5) . In 1986, platelet-derived growth factor (PDGF)' was found to be a powerful vasoconstrictive agent for isolated rat aortic strips (6) . PDGF is produced and secreted by cells of various normal tissues including endothelial cells. Hence, the regulated local secretion of PDGF within the vasculature could play a crucial role in maintaining smooth muscle tone.
PDGF is a ubiquitous growth factor regulating many biological processes in cells of mesenchymal origin, including proliferation and chemotaxis (7) . It has been thought to play a role in normal development as well as in the abnormal proliferation ofcells that occur in diseases such as neoplasia, atherosclerosis, and pulmonary fibrosis (8) (9) (10) . It is composed of two peptides, A and B, that are products of two distinct genes and are regulated independently (11, and this report) . PDGF is active only in the dimeric form and its biological activity is dependent on the particular homo-or heterodimer interacting with the type and number of specific receptors present on the responding mesenchymal cell. It is synthesized and secreted by various other cell types in addition to endothelial cells, including macrophages and smooth muscle cells. Although smooth muscle cells secrete the AA-dimer exclusively, endothelial cells secrete a mixture of PDGF-BB, -AA, and -AB (12) .
The endothelium is in a unique anatomical position in the vasculature to regulate events in the circulating blood cells and the underlying mesenchymal cells. Factors secreted by endothelial cells, such as PDGF, can regulate the proliferative state ofthe surrounding smooth muscle cells as well as modulate the contractile state ofthe vasculature. PDGF production in endothelial cells has been shown to be modestly regulated by factors such as thrombin (threefold induction) (13, 14) , and more dramatically affected by transforming growth factor (# (TGF,) (10-fold upregulation) (15) . In previous studies we have demonstrated a 10-fold downregulation of PDGF by basic fibroblast growth factor (bFGF) (16) . In the studies on early passage cultured endothelium reported here, we explored the possibility that hypoxia, the most potent known physiologic inducer of vasoconstriction, may control vascular smooth muscle tone and blood vessel muscularity by regulating PDGF production in the vasculature. (18) . v-sis is the Simian Sarcoma Virus oncogene that is homologous to c-sis, the normal Bchain gene ofPDGF (19, 20) . The probe for the human PDGF-A chain gene was a 1300-base pair cDNA clone (21) . The TGF, probe used was the 1050-base pair Eco RI fragment corresponding to X#-Cl (22) cubation of cells under hypoxic conditions (Fig. 1 B) . Reexposure to a 21% oxygen atmosphere after incubation in a hypoxic environment resulted in a return of PDGF-B chain mRNA to low (baseline) levels within 24 h (Fig. 2 A) . During the time period ofthe study, endothelial cells in 0% oxygen appeared morphologically normal, continued to produce constitutively other growth factors like TGF, and bFGF, and continued to proliferate as well. Their doubling time was somewhat prolonged: at 3% oxygen, endothelial cells proliferated at a rate equal to that in 21% oxygen; at 1% oxygen, the doubling time was twice that observed at 21% oxygen; while at 0% oxygen, the doubling time was 2.6 times that observed at 21% oxygen.
Hypoxia does not affect PDGF-A chain mRNA. As endothelial cells are known to express both the B-chain as well as the A-chain genes of PDGF, we investigated the possibility that the A-chain mRNA levels may also be regulated by oxygen. However, as shown by cellular RNA blot analysis in Fig. 2 B, a hypoxic environment does not upregulate the A-chain mRNA in these endothelial cells at 48 h (a time at which PDGF-B mRNA is strongly upregulated; see Fig. 1 B) . Transcript levels of other growth factors produced by endothelial cells, including TGFO (Fig. 2 B) , granulocyte-macrophage colony-stimulating factor, and bFGF (data not shown), were also not affected by hypoxia. The amounts of RNA per lane were normalized in all cases after rehybridizing with an actin probe. Actin transcript levels in this system are not affected by oxygen tension (see Fig. 1 Effect of hypoxia on transcriptional rate of the PDGF-B gene. To determine whether the increased steady-state PDGF-B mRNA levels in the presence of hypoxia were a result of enhanced gene transcription or RNA stability, nuclear runoff analyses were carried out. Transcriptional rates were determined 48 h after exposure to a 21 or 1% oxygen environment and were compared with those of the actin gene. As shown in Fig. 3 A, 1% oxygen stimulated B-chain transcription about 10-fold (by densitometry) above the rate observed at 21% oxygen. Actin is transcribed at an equal rate both at 21 and 1% oxygen environments. The half-life of the PDGF-B transcript was 90 min in 1% oxygen and 60 min in 21% oxygen as determined by actinomycin-D chase experiments (data not shown). Thus, the stability of the PDGF-B transcript is slightly prolonged by hypoxia but not so significantly as to account for a 10-fold difference in mRNA levels. The increase in PDGF-B mRNA levels in human umbilical vein endothelial cells is therefore predominantly due to increased gene transcription induced by hypoxia and not to enhanced stability of its mRNA.
Relative B-chain transcript levels (with the mRNA levels at 21% oxygen being made equal to 1) are compared among the different oxygen environments in Fig. 3 B. The accumulation of PDGF-B chain mRNA was progressively enhanced when endothelial cells were exposed to 21, 3, 1, and 0% oxygen tensions. The greatest effect was observed between 0 and 3% oxygen environments. While 3% oxygen resulted in a twofold induction of PDGF-B mRNA over the level observed at 21% (Oxypn%) cells were exposed (0, 1, 3, 21, and 60% oxygen). Cells were exposed to hypoxia for various time periods (24 h-3 d) and a significant induction in PDGF-B mRNA was always observed.
In six separate experiments performed at the 48-h time point, the mean increase in PDGF-B mRNA in response to 1% oxygen environment was 7.2-fold greater than that obtained at 21% oxygen.
oxygen, 0 and 1% oxygen resulted in -10-fold induction. No effect on PDGF-B mRNA levels was observed in enironments with oxygen tensions higher than 21% (ranging up to 60%).
Discussion
Limited information is currently available about the direct influence of hypoxia on biologic activities and functions ofthe endothelium. Other investigators have shown that endothelial cell proliferation at 3% oxygen occurs at a rate similar to that of cells exposed to 21% oxygen but that cells fail to proliferate in complete anoxia (24) . High affinity uptake of serotonin is stimulated in endothelial cells exposed to hypoxia (25) , while synthesis and release of heparan sulfate by bovine pulmonary artery endothelial cells is inhibited by 3% oxygen (26) . Rounds et al. (27) have reported that cultured endothelial cells release a chemoattractant for neutrophils in response to hypoxia. In the studies presented here, we have shown that hypoxia dramatically increases PDGF-B chain mRNA in human umbilical vein endothelial cells. This effect does not appear to be a nonspecific toxic phenomenon of hypoxia, as evidenced by continued cell growth (albeit at a slower rate in 0% oxygen environment) and the unaltered expression of transcripts for other growth factors (TGFO, granulocyte-macrophage colony stimulating factor, and bFGF) and structural proteins (actin) by the endothelial cells. Furthermore, the effect of hypoxia on elevating PDGF transcript levels is reversible.
No significant difference in amounts of PDGF-BB protein produced under the different oxygen environments could be determined by mitogenic assays on growth-arrested fibroblasts, PDGF receptor autophosphorylation, or by metabolic labeling with (35S]methionine/cysteine. PDGF-like protein was detected in small amounts (-1 ng/106 cells/24 h) both in the conditioned media as well as in cell lysates from endothelial cells exposed to 0, 1, or 21% oxygen environments. Based on our studies of mRNA levels, the upregulation of PDGF-B transcripts with hypoxia should result in increased production ofthe B chain. Since the A chain is not affected by hypoxia and PDGF is active only in the dimeric form, increased amounts of the PDGF-BB homodimer should be produced. Bowen-Pope et al. (12) have reported the PDGF-BB dimer to be the least abundant PDGF species, comprising only 15% of the total PDGF secreted by endothelial cells in culture. Even the most sensitive assays used (mitogenesis and receptor autophosphorylation) could not distinguish between the different dimers. Therefore, relatively large increases in the PDGF-BB dimer product, resulting from exposure of endothelial cells to hypoxia, may be difficult to detect within a larger pool of various PDGF dimers. Other inducers of PDGF-A and -B, such as thrombin, TGF,, and phorbol esters, result in a maximum of three-to fivefold increases in total PDGF protein production, despite a 10-fold induction of the gene at the pretranslational level (14, 15) . If this were the case in our system, even a threeto fivefold difference in a relatively small fraction of the total PDGF produced by endothelial cells in culture may result in an undetectable increment over the prolonged (2-3 d) incubation periods used in our experimental systems. Furthermore, differences in compartmentalization, stability, and function of the various PDGF dimers in vivo are also difficult to reproduce in a culture system. Finally, it is less likely but possible that changes in transcription may not correlate with similar changes in translation. Quantitation of the PDGF-BB dimer intra-as well as extracellularly after various periods ofhypoxia are ongoing in our laboratory.
Extrapolation of our findings of transcriptional upregulation of PDGF-B by hypoxia to microvascular endothelial cells suggests that upregulation of PDGF production by the endothelium may be one of the mechanisms responsible for the local regulation of ventilation and perfusion in the lung and for the smooth muscle hypertrophy and vasoconstriction of the pulmonary vasculature seen in response to chronic hypoxia. This regulation occurs over a narrow and physiologic range of oxygen tension, 0-3% environmental oxygen torr) (see Fig. 3 B. ) No further effect is seen on PDGF transcript levels at higher oxygen tension. Studies in our laboratory have shown that the endothelial cell oxygen sensor controlling PDGF production is a heme-containing protein (Kourembanas, S., and D. V. Faller, manuscript in preparation). This narrow and sensitive range of response to oxygen tension might therefore reflect a cooperative effect at the molecular level like that responsbile for the sigmoidal shape of the oxygen-hemoglobin association curve. Endothelial cells in various microvascular beds, like the fetal lung, are normally exposed to -20 Torr of oxygen. The persistent abnormal vasoconstriction and smooth muscle hypertrophy of pulmonary hypertension in the neonate is observed at similar low oxygen levels, conditions that we have shown to result in PDGF upregulation. Thus, the unique anatomical location of vascular endothelial cells, and the fact that they can sense and respond to small changes in oxygen tension, make them attractive candidates as important local regulators ofvascular tone and muscularity.
